Interface Engineering Will Sell, Service Eksigent's HPLCs in S. Korea | GenomeWeb
NEW YORK (GenomeWeb News) — Seoul, South Korea-based Interface Engineering will sell and service Eksigent’s NanoLC and ExpressLC high-performance liquid-chromatography systems in Korea, Eksigent said today.
 
Interface Engineering is a division of Bio-Medical Science Co., a group of Korean distribution and life-science technology companies.
 
Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.